Both in Pharmaceuticals
NRX Pharmaceuticals vs Anixa Biosciences
Over the past year NRXP returned −24.8% and ANIX returned −23.2%; their daily moves had a correlation of 0.19.
NRXP −24.8% ANIX −23.2%Growth of $1, one year, split-adjusted
| Metric | NRXP | ANIX |
|---|---|---|
| Price | $2.27 | $3.12 |
| Market cap | $98.3M | $108.5M |
| Today | −14.66% | −5.45% |
| 1 month | −20.4% | +12.6% |
| 6 months | −26.5% | −0.6% |
| Year to date | −16.2% | 0.0% |
| 1 year | −25.6% | −25.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | 38.7% | — |
| Net margin | −1500.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 29.0× | — |
| Net cash | $26.3M | $13.9M |
| Dividend yield | — | — |
| Volatility (60d) | 65.5% | 58.9% |
| Short % of float | 29.3% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).